Latest Breaking News On - Sanjay nayak - Page 1 : vimarsana.com

Ocular Therapeutix, Inc. (NASDAQ:OCUL – Get Free Report) insider Sanjay Nayak sold 2,274 shares of Ocular Therapeutix stock in a transaction on Thursday, May 23rd. The shares were sold at an average price of $5.84, for a total value of $13,280.16. Following the sale, the insider now directly owns 178,026 shares of the company’s stock, […]

New yorkUnited statesSanjay nayakPiper sandlerRaymond james associatesOcular therapeutix incRafferty asset managementYork state common retirement fundRaymond james financial services advisors incBarclays plcSecurities exchange commissionOcular therapeutixGet free reportExchange commissionJames financial services advisorsOcular therapeutix daily